The expression of NAMPT, the rate-limiting enzyme in the salvage NAD+ biosynthetic pathway, decreases with aging and obesity in various organs, including in white and brown adipose tissue, liver, skeletal muscle, hippocampus, and retina [42,47,63,64,65,66]. Here, NAMPT is linked to obesity disorder.